Identifying children with sickle cell anaemia in a non-endemic country: age at diagnosis and presenting symptoms.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Sickle Cell Disease in Early Infancy: A Case Report.Pediatric health, medicine and therapeutics · 2022
   Article
2. Age at diagnosis of sickle cell anaemia in lagos, Nigeria.Mediterranean journal of hematology and infectious diseases · 2013
   Article
3. A case study of haemoglobinopathy screening in the Netherlands: witnessing the past, lessons for the future.Ethnicity & health · 2012
   Article
4. Bacterial meningitis in patients with sickle cell anemia in Salvador, Bahia, Brazil: a report on ten cases.Hematology, transfusion and cell therapy
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as